1 Market Overview
1.1 Product Overview and Scope of Letermovir Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Letermovir Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 240 mg/12 mL (20 mg/mL)
1.3.3 480 mg/24 mL (20 mg/mL)
1.4 Market Analysis by Application
1.4.1 Overview: Global Letermovir Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Letermovir Injection Market Size & Forecast
1.5.1 Global Letermovir Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Letermovir Injection Sales Quantity (2018-2029)
1.5.3 Global Letermovir Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Letermovir Injection Product and Services
2.1.4 Merck Letermovir Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
3 Competitive Environment: Letermovir Injection by Manufacturer
3.1 Global Letermovir Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Letermovir Injection Revenue by Manufacturer (2018-2023)
3.3 Global Letermovir Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Letermovir Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Letermovir Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Letermovir Injection Manufacturer Market Share in 2022
3.5 Letermovir Injection Market: Overall Company Footprint Analysis
3.5.1 Letermovir Injection Market: Region Footprint
3.5.2 Letermovir Injection Market: Company Product Type Footprint
3.5.3 Letermovir Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Letermovir Injection Market Size by Region
4.1.1 Global Letermovir Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Letermovir Injection Consumption Value by Region (2018-2029)
4.1.3 Global Letermovir Injection Average Price by Region (2018-2029)
4.2 North America Letermovir Injection Consumption Value (2018-2029)
4.3 Europe Letermovir Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Letermovir Injection Consumption Value (2018-2029)
4.5 South America Letermovir Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Letermovir Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Letermovir Injection Sales Quantity by Type (2018-2029)
5.2 Global Letermovir Injection Consumption Value by Type (2018-2029)
5.3 Global Letermovir Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Letermovir Injection Sales Quantity by Application (2018-2029)
6.2 Global Letermovir Injection Consumption Value by Application (2018-2029)
6.3 Global Letermovir Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Letermovir Injection Sales Quantity by Type (2018-2029)
7.2 North America Letermovir Injection Sales Quantity by Application (2018-2029)
7.3 North America Letermovir Injection Market Size by Country
7.3.1 North America Letermovir Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Letermovir Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Letermovir Injection Sales Quantity by Type (2018-2029)
8.2 Europe Letermovir Injection Sales Quantity by Application (2018-2029)
8.3 Europe Letermovir Injection Market Size by Country
8.3.1 Europe Letermovir Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Letermovir Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Letermovir Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Letermovir Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Letermovir Injection Market Size by Region
9.3.1 Asia-Pacific Letermovir Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Letermovir Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Letermovir Injection Sales Quantity by Type (2018-2029)
10.2 South America Letermovir Injection Sales Quantity by Application (2018-2029)
10.3 South America Letermovir Injection Market Size by Country
10.3.1 South America Letermovir Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Letermovir Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Letermovir Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Letermovir Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Letermovir Injection Market Size by Country
11.3.1 Middle East & Africa Letermovir Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Letermovir Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Letermovir Injection Market Drivers
12.2 Letermovir Injection Market Restraints
12.3 Letermovir Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Letermovir Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Letermovir Injection
13.3 Letermovir Injection Production Process
13.4 Letermovir Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Letermovir Injection Typical Distributors
14.3 Letermovir Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Letermovir Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Letermovir Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Letermovir Injection Product and Services
Table 6. Merck Letermovir Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Global Letermovir Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 9. Global Letermovir Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 10. Global Letermovir Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 11. Market Position of Manufacturers in Letermovir Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 12. Head Office and Letermovir Injection Production Site of Key Manufacturer
Table 13. Letermovir Injection Market: Company Product Type Footprint
Table 14. Letermovir Injection Market: Company Product Application Footprint
Table 15. Letermovir Injection New Market Entrants and Barriers to Market Entry
Table 16. Letermovir Injection Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Letermovir Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 18. Global Letermovir Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 19. Global Letermovir Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 20. Global Letermovir Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 21. Global Letermovir Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 22. Global Letermovir Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 23. Global Letermovir Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 24. Global Letermovir Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 25. Global Letermovir Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 26. Global Letermovir Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 27. Global Letermovir Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 28. Global Letermovir Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 29. Global Letermovir Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 30. Global Letermovir Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 31. Global Letermovir Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 32. Global Letermovir Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 33. Global Letermovir Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 34. Global Letermovir Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 35. North America Letermovir Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 36. North America Letermovir Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 37. North America Letermovir Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 38. North America Letermovir Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 39. North America Letermovir Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 40. North America Letermovir Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 41. North America Letermovir Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 42. North America Letermovir Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 43. Europe Letermovir Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Europe Letermovir Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Europe Letermovir Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 46. Europe Letermovir Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 47. Europe Letermovir Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 48. Europe Letermovir Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 49. Europe Letermovir Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 50. Europe Letermovir Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 51. Asia-Pacific Letermovir Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 52. Asia-Pacific Letermovir Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 53. Asia-Pacific Letermovir Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 54. Asia-Pacific Letermovir Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 55. Asia-Pacific Letermovir Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 56. Asia-Pacific Letermovir Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 57. Asia-Pacific Letermovir Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 58. Asia-Pacific Letermovir Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 59. South America Letermovir Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 60. South America Letermovir Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 61. South America Letermovir Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 62. South America Letermovir Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 63. South America Letermovir Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 64. South America Letermovir Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 65. South America Letermovir Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 66. South America Letermovir Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 67. Middle East & Africa Letermovir Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 68. Middle East & Africa Letermovir Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 69. Middle East & Africa Letermovir Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Middle East & Africa Letermovir Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Middle East & Africa Letermovir Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 72. Middle East & Africa Letermovir Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 73. Middle East & Africa Letermovir Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 74. Middle East & Africa Letermovir Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 75. Letermovir Injection Raw Material
Table 76. Key Manufacturers of Letermovir Injection Raw Materials
Table 77. Letermovir Injection Typical Distributors
Table 78. Letermovir Injection Typical Customers
List of Figures
Figure 1. Letermovir Injection Picture
Figure 2. Global Letermovir Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Letermovir Injection Consumption Value Market Share by Type in 2022
Figure 4. 240 mg/12 mL (20 mg/mL) Examples
Figure 5. 480 mg/24 mL (20 mg/mL) Examples
Figure 6. Global Letermovir Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Letermovir Injection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Letermovir Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Letermovir Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Letermovir Injection Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Letermovir Injection Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Letermovir Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Letermovir Injection Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Letermovir Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Letermovir Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Letermovir Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Letermovir Injection Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Letermovir Injection Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Letermovir Injection Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Letermovir Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Letermovir Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Letermovir Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Letermovir Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Letermovir Injection Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Letermovir Injection Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Letermovir Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Letermovir Injection Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Letermovir Injection Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Letermovir Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Letermovir Injection Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Letermovir Injection Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Letermovir Injection Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Letermovir Injection Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Letermovir Injection Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Letermovir Injection Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Letermovir Injection Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Letermovir Injection Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Letermovir Injection Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Letermovir Injection Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Letermovir Injection Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Letermovir Injection Consumption Value Market Share by Region (2018-2029)
Figure 53. China Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Letermovir Injection Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Letermovir Injection Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Letermovir Injection Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Letermovir Injection Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Letermovir Injection Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Letermovir Injection Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Letermovir Injection Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Letermovir Injection Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Letermovir Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Letermovir Injection Market Drivers
Figure 74. Letermovir Injection Market Restraints
Figure 75. Letermovir Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Letermovir Injection in 2022
Figure 78. Manufacturing Process Analysis of Letermovir Injection
Figure 79. Letermovir Injection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
